These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Proceedings: Further studies on the mode of action of ergotamine on canine vein strips. Müller-Schweinitzer E Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R68. PubMed ID: 4276620 [No Abstract] [Full Text] [Related]
4. Studies on the mechanism of the venoconstrictor activity of ergotamine on isolated canine saphenous veins. Müller-Schweinitzer E; Stürmer E Blood Vessels; 1974; 11(3):183-90. PubMed ID: 4451730 [No Abstract] [Full Text] [Related]
5. Studies on the peripheral mode of action of dihydroergotamine in human and canine veins. Müller-Schweinitzer E Eur J Pharmacol; 1974 Jul; 27(2):231-7. PubMed ID: 4854492 [No Abstract] [Full Text] [Related]
6. Effects of indomethacin on venoconstrictor responses to bradykinin and norepinephrine. Goldberg MR; Joiner PD; Greenberg S; Hyman AL; Kadowitz PJ Prostaglandins; 1975 Mar; 9(3):385-90. PubMed ID: 1138295 [TBL] [Abstract][Full Text] [Related]
7. Investigations on the mode of action of ergotamine in the isolated femoral vein of the dog. Müller-Schweinitzer E; Stürmer E Br J Pharmacol; 1974 Jul; 51(3):441-6. PubMed ID: 4155973 [TBL] [Abstract][Full Text] [Related]
8. Evidence for stimulation of 5-HT receptors in canine saphenous arteries by ergotamine. Müller-Schweinitzer E Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):41-4. PubMed ID: 1004641 [TBL] [Abstract][Full Text] [Related]
9. Influence of inhibitors of prostaglandin synthesis on venoconstrictor responses to bradykinin. Goldberg MR; Chapnick BM; Joiner PD; Hyman AL; Kadowitz PJ J Pharmacol Exp Ther; 1976 Aug; 198(2):357-65. PubMed ID: 948031 [TBL] [Abstract][Full Text] [Related]
10. On the pharmacology of venous smooth muscle from dog and man. Müller-Schweinitzer E Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):690-704. PubMed ID: 94863 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological basis of the treatment of orthostatic disorders with ergot alkaloids. Stürmer E Cardiology; 1976; 61 suppl 1():290-301. PubMed ID: 975143 [TBL] [Abstract][Full Text] [Related]
14. Selective inhibitory actions of sodium-p-benzyl-4-[1-oxo-2-(4-chlorobenzyl)-3-phenyl propyl] phenyl phosphonate (N-0161) and indomethacin on the biosynthesis of prostaglandins and thromboxanes from arachidonic acid. Eakins KE; Kulkarni PS Br J Pharmacol; 1977 May; 60(1):135-40. PubMed ID: 884384 [TBL] [Abstract][Full Text] [Related]
15. Role of alpha-adrenoceptors in prostaglandin E mediated negative feedback control of the secretion of noradrenaline from the sympathetic nerves of isolated guinea-pig vas deferens. Stjärne L Prostaglandins; 1973 Dec; 4(6):845-51. PubMed ID: 4150246 [No Abstract] [Full Text] [Related]
16. Venous responses to prostaglandin F2 alpha. Mark AL; Schmid PG; Eckstein JW; Wendling MG Am J Physiol; 1971 Jan; 220(1):222-6. PubMed ID: 4992254 [No Abstract] [Full Text] [Related]
17. Effects of prostaglandin B2 on vascular tone and reactivity. Greenberg S; Diecke FP; Kadowitz PJ; Long JP Life Sci; 1975 Feb; 16(3):363-74. PubMed ID: 1128154 [No Abstract] [Full Text] [Related]
18. Evidence for enhanced venous smooth muscle turnover of prostaglandin-like substance in portal veins from spontaneously hypertensive rats. Greenberg S Prostaglandins; 1976 Jan; 11(1):163-93. PubMed ID: 815963 [TBL] [Abstract][Full Text] [Related]
19. Effects of ergotamine on isolated human vessels. Mikkelsen E; Pedersen OL; Ostergaard JR; Pedersen SE Arch Int Pharmacodyn Ther; 1981 Aug; 252(2):241-52. PubMed ID: 7305561 [TBL] [Abstract][Full Text] [Related]
20. Inhibition by acetylcholine of the norepinephrine release evoked by potassium in canine saphenous veins. Vanhoutee PM; Verbeuren TJ Circ Res; 1976 Aug; 39(2):263-9. PubMed ID: 939012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]